Gene expression changes in the medial prefrontal cortex and nucleus accumbens following abstinence from cocaine self-administration. 2010

Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
Department of Pharmacology, Penn State College of Medicine, Hershey, PA 17033, USA. wfreeman@psu.edu

BACKGROUND Many studies of cocaine-responsive gene expression have focused on changes occurring during cocaine exposure, but few studies have examined the persistence of these changes with cocaine abstinence. Persistent changes in gene expression, as well as alterations induced during abstinence may underlie long-lasting drug craving and relapse liability. RESULTS Whole-genome expression analysis was conducted on a rat cocaine binge-abstinence model that has previously been demonstrated to engender increased drug seeking and taking with abstinence. Gene expression changes in two mesolimbic terminal fields (mPFC and NAc) were identified in a comparison of cocaine-naïve rats with rats after 10 days of cocaine self-administration followed by 1, 10, or 100 days of enforced abstinence (n = 6-11 per group). A total of 1,461 genes in the mPFC and 414 genes in the NAc were altered between at least two time points (ANOVA, p < 0.05; +/- 1.4 fold-change). These genes can be subdivided into: 1) changes with cocaine self-administration that do not persist into periods of abstinence, 2) changes with cocaine self-administration that persist with abstinence, 3) and those not changed with cocaine self-administration, but changed during enforced abstinence. qPCR analysis was conducted to confirm gene expression changes observed in the microarray analysis. CONCLUSIONS Together, these changes help to illuminate processes and networks involved in abstinence-induced behaviors, including synaptic plasticity, MAPK signaling, and TNF signaling.

UI MeSH Term Description Entries
D008297 Male Males
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
February 2014, The international journal of neuropsychopharmacology,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
May 1993, The Journal of pharmacology and experimental therapeutics,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
June 2023, Molecular and cellular neurosciences,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
January 2000, Neuroscience,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
January 2004, Neuroscience letters,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
February 2020, Scientific reports,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
July 1994, Psychopharmacology,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
May 1999, Synapse (New York, N.Y.),
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
September 1999, The European journal of neuroscience,
Willard M Freeman, and Melinda E Lull, and Kruti M Patel, and Robert M Brucklacher, and Drake Morgan, and David C S Roberts, and Kent E Vrana
November 2015, Scientific reports,
Copied contents to your clipboard!